In this episode, host Taylor sits down with Pulak and Priyanka Sharma, co-founders of Kazmira and experts in pharmaceutical-grade cannabinoid manufacturing, to discuss the evolution of CBD from a fragmented retail product to a standardized, prescription-based medical solution.
What You’ll Learn
- Why standardization and quality control are critical in emerging industries like cannabinoids
- How Pulak and Priyanka leveraged chemical engineering and oil & gas experience to build a regulated healthcare platform
- The shift from commoditized retail CBD to clinically guided, prescription-based treatments
- How vertical integration enables better control, trust, and outcomes in healthcare products
- The role of telemedicine in expanding access to personalized treatments
- Why personalization is becoming essential in modern medicine due to diverse patient populations
- Key macro trends shaping healthcare, including EHR adoption, telehealth growth, and physician shortages
- How compounded pharmacy models are driving the future of customized medicine
Pulak and Priyanka highlight how aligning with long-term healthcare trend, standardization, personalization, and digital access, can transform a volatile market into a trusted medical ecosystem. Their journey reflects the importance of building infrastructure and credibility early in emerging industries to create lasting impact and scalable growth.
To learn more about Pulak and Priyanka Sharma and their work, visit kazmiratx.com